Cargando…

Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101

The aim of this study was to explore the effects of herbal drug pharmacokinetic interactions on the biotransformation of molnupiravir and its metabolite β-D-N4-hydroxycytidine (NHC) in the blood and brain. To investigate the biotransformation mechanism, a carboxylesterase inhibitor, bis(4-nitropheny...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chun-Hao, Peng, Wen-Ya, Lee, Wan-Hsin, Lin, Tung-Yi, Yang, Muh-Hwa, Dalley, Jeffrey W., Tsai, Tung-Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228170/
https://www.ncbi.nlm.nih.gov/pubmed/37302376
http://dx.doi.org/10.1016/j.jpba.2023.115499
_version_ 1785050913000390656
author Chang, Chun-Hao
Peng, Wen-Ya
Lee, Wan-Hsin
Lin, Tung-Yi
Yang, Muh-Hwa
Dalley, Jeffrey W.
Tsai, Tung-Hu
author_facet Chang, Chun-Hao
Peng, Wen-Ya
Lee, Wan-Hsin
Lin, Tung-Yi
Yang, Muh-Hwa
Dalley, Jeffrey W.
Tsai, Tung-Hu
author_sort Chang, Chun-Hao
collection PubMed
description The aim of this study was to explore the effects of herbal drug pharmacokinetic interactions on the biotransformation of molnupiravir and its metabolite β-D-N4-hydroxycytidine (NHC) in the blood and brain. To investigate the biotransformation mechanism, a carboxylesterase inhibitor, bis(4-nitrophenyl)phosphate (BNPP), was administered. Not only molnupiravir but also the herbal medicine Scutellaria formula-NRICM101 is potentially affected by coadministration with molnupiravir. However, the herb-drug interaction between molnupiravir and the Scutellaria formula-NRICM101 has not yet been investigated. We hypothesized that the complex bioactive herbal ingredients in the extract of the Scutellaria formula-NRICM101, the biotransformation and penetration of the blood—brain barrier of molnupiravir are altered by inhibition of carboxylesterase. To monitor the analytes, ultrahigh-performance liquid chromatography tandem mass spectrometry (UHPLC—MS/MS) coupled with the microdialysis method was developed. Based on the dose transfer from humans to rats, a dose of molnupiravir (100 mg/kg, i.v.), molnupiravir (100 mg/kg, i.v.) + BNPP (50 mg/kg, i.v.), and molnupiravir (100 mg/kg, i.v.) + the Scutellaria formula-NRICM101 extract (1.27 g/kg, per day, for 5 consecutive days) were administered. The results showed that molnupiravir was rapidly metabolized to NHC and penetrated into the brain striatum. However, when concomitant with BNPP, NHC was suppressed, and molnupiravir was enhanced. The blood-to-brain penetration ratios were 2% and 6%, respectively. In summary, the extract of the Scutellaria formula-NRICM101 provides a pharmacological effect similar to that of the carboxylesterase inhibitor to suppress NHC in the blood, and the brain penetration ratio was increased, but the concentration is also higher than the effective concentration in the blood and brain.
format Online
Article
Text
id pubmed-10228170
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-102281702023-05-30 Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101 Chang, Chun-Hao Peng, Wen-Ya Lee, Wan-Hsin Lin, Tung-Yi Yang, Muh-Hwa Dalley, Jeffrey W. Tsai, Tung-Hu J Pharm Biomed Anal Article The aim of this study was to explore the effects of herbal drug pharmacokinetic interactions on the biotransformation of molnupiravir and its metabolite β-D-N4-hydroxycytidine (NHC) in the blood and brain. To investigate the biotransformation mechanism, a carboxylesterase inhibitor, bis(4-nitrophenyl)phosphate (BNPP), was administered. Not only molnupiravir but also the herbal medicine Scutellaria formula-NRICM101 is potentially affected by coadministration with molnupiravir. However, the herb-drug interaction between molnupiravir and the Scutellaria formula-NRICM101 has not yet been investigated. We hypothesized that the complex bioactive herbal ingredients in the extract of the Scutellaria formula-NRICM101, the biotransformation and penetration of the blood—brain barrier of molnupiravir are altered by inhibition of carboxylesterase. To monitor the analytes, ultrahigh-performance liquid chromatography tandem mass spectrometry (UHPLC—MS/MS) coupled with the microdialysis method was developed. Based on the dose transfer from humans to rats, a dose of molnupiravir (100 mg/kg, i.v.), molnupiravir (100 mg/kg, i.v.) + BNPP (50 mg/kg, i.v.), and molnupiravir (100 mg/kg, i.v.) + the Scutellaria formula-NRICM101 extract (1.27 g/kg, per day, for 5 consecutive days) were administered. The results showed that molnupiravir was rapidly metabolized to NHC and penetrated into the brain striatum. However, when concomitant with BNPP, NHC was suppressed, and molnupiravir was enhanced. The blood-to-brain penetration ratios were 2% and 6%, respectively. In summary, the extract of the Scutellaria formula-NRICM101 provides a pharmacological effect similar to that of the carboxylesterase inhibitor to suppress NHC in the blood, and the brain penetration ratio was increased, but the concentration is also higher than the effective concentration in the blood and brain. Elsevier B.V. 2023-09-20 2023-05-30 /pmc/articles/PMC10228170/ /pubmed/37302376 http://dx.doi.org/10.1016/j.jpba.2023.115499 Text en © 2023 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Chang, Chun-Hao
Peng, Wen-Ya
Lee, Wan-Hsin
Lin, Tung-Yi
Yang, Muh-Hwa
Dalley, Jeffrey W.
Tsai, Tung-Hu
Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
title Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
title_full Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
title_fullStr Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
title_full_unstemmed Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
title_short Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
title_sort biotransformation and brain distribution of the anti-covid-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract scutellaria formula-nricm101
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228170/
https://www.ncbi.nlm.nih.gov/pubmed/37302376
http://dx.doi.org/10.1016/j.jpba.2023.115499
work_keys_str_mv AT changchunhao biotransformationandbraindistributionoftheanticovid19drugmolnupiravirandherbdrugpharmacokineticinteractionsbetweentheherbalextractscutellariaformulanricm101
AT pengwenya biotransformationandbraindistributionoftheanticovid19drugmolnupiravirandherbdrugpharmacokineticinteractionsbetweentheherbalextractscutellariaformulanricm101
AT leewanhsin biotransformationandbraindistributionoftheanticovid19drugmolnupiravirandherbdrugpharmacokineticinteractionsbetweentheherbalextractscutellariaformulanricm101
AT lintungyi biotransformationandbraindistributionoftheanticovid19drugmolnupiravirandherbdrugpharmacokineticinteractionsbetweentheherbalextractscutellariaformulanricm101
AT yangmuhhwa biotransformationandbraindistributionoftheanticovid19drugmolnupiravirandherbdrugpharmacokineticinteractionsbetweentheherbalextractscutellariaformulanricm101
AT dalleyjeffreyw biotransformationandbraindistributionoftheanticovid19drugmolnupiravirandherbdrugpharmacokineticinteractionsbetweentheherbalextractscutellariaformulanricm101
AT tsaitunghu biotransformationandbraindistributionoftheanticovid19drugmolnupiravirandherbdrugpharmacokineticinteractionsbetweentheherbalextractscutellariaformulanricm101